Exploratory analysis of tumor growth rate in patients (pts) with advanced gastrointestinal stromal tumors (GIST) treated with regorafenib (REG) in the GRID phase 3 trial
ONCOLOGY RESEARCH AND TREATMENT（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要